Table 3 Factors associated with transfusions in both arms
From: Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
Group without EPO | Group with EPO | |||||
|---|---|---|---|---|---|---|
OR | 95%CI | p | OR | 95%CI | p | |
Age | 1.03 | 0.98,1.09 | 0.250 | 1.01 | 0.97,1.05 | 0.599 |
Gender Ref: Male | 0.73 | 0.26,2.03 | 0.545 | 1.42 | 0.51,3.96 | 0.502 |
Smoking | 4.00 | 1.09,14.66 | 0.036 | 0.70 | 0.25,1.99 | 0.507 |
Diabetes | 1.37 | 0.49,3.82 | 0.545 | 1.08 | 0.39,2.99 | 0.877 |
Previous CVD | 0.88 | 0.32,2.43 | 0.798 | 1.91 | 0.66,5.54 | 0.237 |
COPD | 2.93 | 0.78, 0.97 | 0.111 | 0.76 | 0.25,2.33 | 0.627 |
NSAIDs prior use | 1.37 | 0.21,8.84 | 0.743 | 1.91 | 0.11,32.01 | 0.653 |
Baseline eGFR | 0.99 | 0.97,1.02 | 0.722 | 0.99 | 0.97,1.01 | 0.331 |
AKI stage 2 or 3 Ref: AKI stage 1 | 1.05 | 0.38,2.89 | 0.932 | 1.58 | 0.57,4.35 | 0.380 |
Hemoglobin T1 | 0.26 | 0.13,0.51 | < 0.001 | 0.35 | 0.19,0.65 | 0.001 |
Serum creatinine T1 | 1.01 | 0.84,1.19 | 0.958 | 1.21 | 0.99,1.46 | 0.058 |
CRP T1 | 1.00 | 0.99,1.01 | 0.444 | 1.00 | 0.99,1.01 | 0.490 |
Platelets' count | 1.00 | 1.00, 1.00 | 0.476 | 1.00 | 1.00, 1.00 | 0.055 |
Ferritin | 1.00 | 0.99,1.00 | 0.278 | 1.04 | 0.99,1.00 | 0.198 |
Iron intake | 1.32 | 0.38,4.65 | 0.662 | 0.41 | 0.13,1.31 | 0.133 |
Anticoagulation | 2.24 | 0.77,6.54 | 0.140 | 3.13 | 0.98,9.97 | 0.053 |
Corticosteroid use | 3.40 | 1.14,10.15 | 0.028 | 1.29 | 0.45,3.69 | 0.641 |
Vasopressor use | 6.47 | 0.63,66.38 | 0.116 | 0.69 | 0.19,2.52 | 0.580 |